4//SEC Filing
INOTEK PHARMACEUTICALS CORP 4
Accession 0001140361-17-001008
$RCKTCIK 0001281895operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:03 PM ET
Size
10.5 KB
Accession
0001140361-17-001008
Insider Transaction Report
Form 4
Devon Park Associates, L.P.
10% Owner
Transactions
- Other
Common Stock
2017-01-04−9,857→ 0 total(indirect: See Footnote) - Other
Common Stock
2017-01-04−3,243,709→ 9,857 total(indirect: See Footnote)
DEVON PARK BIOVENTURES LP
10% Owner
Transactions
- Other
Common Stock
2017-01-04−9,857→ 0 total(indirect: See Footnote) - Other
Common Stock
2017-01-04−3,243,709→ 9,857 total(indirect: See Footnote)
Devon Park Associates, LLC
10% Owner
Transactions
- Other
Common Stock
2017-01-04−3,243,709→ 9,857 total(indirect: See Footnote) - Other
Common Stock
2017-01-04−9,857→ 0 total(indirect: See Footnote)
Footnotes (4)
- [F1]Devon Park Bioventures, L.P. conducted an in-kind, pro rata distribution to its limited partners of all shares of the Issuer's common stock owned by it.
- [F2]Represents the beneficial ownership of shares of the Issuer's common stock held directly by Devon Park Bioventures, L.P. Devon Park Associates, LLC is the general partner of Devon Park Associates, L.P., which is the general partner of Devon Park Bioventures, L.P.
- [F3]Devon Park Associates, L.P. conducted an in-kind, pro rata distribution to its limited partners of all shares of the Issuer's common stock owned by it.
- [F4]Represents the beneficial ownership of shares of the Issuer's common stock held directly by Devon Park Associates, L.P. Devon Park Associates, LLC is the general partner of Devon Park Associates, L.P.
Documents
Issuer
INOTEK PHARMACEUTICALS CORP
CIK 0001281895
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001281895
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:03 PM ET
- Size
- 10.5 KB